← TrialMatch
HomeTrials

Balance Amongst Patients With Lumbar Spinal Stenosis

Lumbar spinal stenosis (LSS) is one of the most common degenerative diseases of the spinal column, with symptoms including low back pain which worsens with ambulation, poor balance, decreased activity due to pain, and a marked decrease in quality of life (QoL). Prevalence rises with age, and current treatment options r

Condition(s)Lumbar Spinal Stenosis
StatusRecruiting
Study typeObservational
SummaryLumbar spinal stenosis (LSS) is one of the most common degenerative diseases of the spinal column, with symptoms including low back pain which worsens with ambulation, poor balance, decreased activity due to pain, and a marked decrease in quality of life (QoL). Prevalence rises with age, and current treatment options range from varied conservative management strategies, to surgical intervention with decompression of neural structures. While the effects of surgical decompression on back pain and QoL has been widely researched, the effects of surgery on patient balance is less well understood. Though patients generally have subjective improvements in this parameter after surgery, objective measurements in this patient group have been lacking. This study aims to investigate the effects of dec
Who can participateInclusion Criteria: * Age ≥ 65 years * Referred to decompressive spinal surgery due to symptomatic lumbar spinal stenosis at ≥ 1 level * Central canal LSS grade B or C (Schizas classification) at ≥ 1 level by Magnetic Resonance Imaging * Minimum of 3 months of unsuccessful non-operative treatment Exclusion Criteria: * Signs of malignancy or infection in the spinal column * Severe comorbidities incl. neurodegenerative conditions which may contribute to balance problems * Revision surgery (previous decompression surgery at the same vertebral level) * Spinal surgery up to 1 year prior to the date of inclusion * Mini Mental State Exam (MMSE) score of ≤ 27 points * Degenerative spondylolisthesis more than 3mm on pre-operative imaging diagnostics
Ages65 Years
SexAll
Lead sponsorRegion Zealand
LocationsKøge, Denmark; Middelfart, Denmark
Start date2023-09-21
NCT IDNCT06075862
Official listinghttps://clinicaltrials.gov/study/NCT06075862

🔍 Search all trials →